Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ENvue Medical (FEED) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for ENvue Medical (FEED) over the last 8 years, with Q3 2025 value amounting to 0.23%.

  • ENvue Medical's Return on Capital Employed rose 8600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year increase of 8600.0%. This contributed to the annual value of 1.47% for FY2024, which is 5800.0% down from last year.
  • Latest data reveals that ENvue Medical reported Return on Capital Employed of 0.23% as of Q3 2025, which was up 8600.0% from 0.2% recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Return on Capital Employed registered a high of 0.2% during Q2 2025, and its lowest value of 2.5% during Q4 2024.
  • For the 5-year period, ENvue Medical's Return on Capital Employed averaged around 1.04%, with its median value being 0.78% (2021).
  • Over the last 5 years, ENvue Medical's Return on Capital Employed had its largest YoY gain of 24500bps in 2021, and its largest YoY loss of -244600bps in 2021.
  • Over the past 5 years, ENvue Medical's Return on Capital Employed (Quarter) stood at 0.78% in 2021, then tumbled by -98bps to 1.55% in 2022, then surged by 51bps to 0.75% in 2023, then plummeted by -232bps to 2.5% in 2024, then soared by 91bps to 0.23% in 2025.
  • Its Return on Capital Employed was 0.23% in Q3 2025, compared to 0.2% in Q2 2025 and 0.31% in Q1 2025.